1. Home
  2. DVA

as 12-26-2024 4:00pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Misc Health and Biotechnology Services

Nasdaq

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

Founded: 1994 Country:
United States
United States
Employees: N/A City: DENVER
Market Cap: 12.6B IPO Year: 1995
Target Price: $153.40 AVG Volume (30 days): 652.4K
Analyst Decision: Hold Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 9.24 EPS Growth: 41.03
52 Week Low/High: $103.40 - $169.52 Next Earning Date: 02-11-2025
Revenue: $12,666,614,000 Revenue Growth: 6.34%
Revenue Growth (this year): 6.17% Revenue Growth (next year): 3.56%

DVA Daily Stock ML Predictions

Share on Social Networks: